Manila Times Business
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD
- Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War - KENMORE, N.Y, June 02, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly” or the "Company”) (NASDAQ: AIFF), an Artificial Intelligence ("AI”) company advancing precision neuroscience, today announced the identification of a novel electrophysiological biomarker for Post-Traumatic Stress Disorder ("PTSD”) using brain scans collected on its FDA-510(k)-cleared Evoke System.
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Diamond drilling program under way at Leviathan Metals’ Central Project, Kalahari Copper Belt, Botswana
1h ago
Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome
1h ago
Paychex Small Business Jobs Index Improves for a Third Consecutive Month
1h ago
Safe Pro Awarded U.S. Army Order For AI-Powered Threat Analysis Kit Together with Red Cat Black Widow Drones
1h ago